Up around 2.5x from its low in March 2020, at the current price of $126 per share, we believe EXACT Sciences Corporation stock has further upside potential. EXAS, a molecular diagnostics company, has seen its stock rise from $51 to $126 off its March 2020 low, much more than the S&P which increased.
Read More
/https://specials-images.forbesimg.com/imageserve/60cc3d378e3d68446c7450b8/0x0.jpg)
